Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1999-04-08
2000-12-12
Guzo, David
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
435 911, 435325, 536 231, 536 243, 536 245, C12Q 168, C07H 2104, C12N 1585
Patent
active
061596949
ABSTRACT:
Compounds, compositions and methods are provided for inhibiting the expression of human STAT3. The compositions comprise antisense oligonucleotides targeted to nucleic acids encoding STAT3. Methods of using these oligonucleotides for inhibition of STAT3 expression and for treatment of diseases, particularly inflammatory diseases and cancers, associated with overexpression or constitutive activation of STAT3 are provided.
REFERENCES:
patent: 5719042 (1998-02-01), Kishimoto et al.
patent: 5801154 (1998-09-01), Baracchini et al.
patent: 5844082 (1998-12-01), Kishimoto et al.
Grandis et al., J. Clinic. Invest. 102: 1385-1392, Oct. 1, 1998.
Ernst et al., J. Biol. Chem. 274:9729-9737, Apr. 2, 1999.
Branch TIBS 23:45-50, Feb. 1998.
Crooke, S. T. Ch1, "Antisense Research & Application", Springes, N,Y. 1998, pp. 1-50.
James Antiviral Chem. & Chemotherp. 2: 191-214, 1991.
Milner et al., Nature Biotechnol. 15: 537-541 1997.
Grandis et al., "Requirement of Stat3 but not Stat1 Activation for Epidermal Growth Factor Receptor-mediated Cell Growth in Vitro", J. Clin. Invest., 1998, 102, 1385-1392.
Guzo David
Isis Pharmaceuticals , Inc.
Wang Andrew
LandOfFree
Antisense modulation of stat3 expression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense modulation of stat3 expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense modulation of stat3 expression will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-215400